greeksoup/ stock research
Stock research / United States / AZN / Year to 31 December 2020

AstraZeneca PLC (AZN) annual results, year to 31 December 2020: revenue USD 26,617 million, from the 20-F

AstraZeneca PLC files a 20-F with the SEC once a year, in US dollars. In the year to 31 December 2020 it reported revenue of USD 26,617 million, up 9.2% on the year before. Its profit attributable to shareholders was USD 3,196 million, up 139.4%, and diluted earnings per share USD 2.44.

Revenue
USD 26,617 million
+9.2% on the year
FY2015FY2020
Operating margin
19.4%
12.0% a year earlier
FY2015FY2020
Net income
USD 3,196 million
+139.4% on the year
FY2015FY2020
Diluted EPS
USD 2.44
+136.9% on the year
FY2015FY2020

this yearthe year beforeIn US dollars as filed. Hover a bar for its figure.

Income statement (profit and loss)

Year toDec 2019Dec 2020
Revenue24,38426,617
Cost of sales4,9215,299
Gross profit19,46321,318
Research and development6,0595,991
Selling, general and administrative11,68211,294
Operating profit2,9245,162
Finance costs1,4321,306
Profit before tax1,5483,916
Income tax321772
Profit for the year1,2273,144
Profit attributable to shareholders1,3353,196
Filing20-F20-F
USD million, from the 20-F on the SEC's EDGAR, linked in the last row, on the IFRS tags the company filed.
Read moreA line the company does not file under the standard tag is left out rather than estimated.
Year toDec 2019Dec 2020
Diluted EPS1.032.44
Basic EPS1.032.44
Filing20-F20-F

USD per ordinary share, as filed.

Cash flow

Year toDec 2019Dec 2020
Cash from operations2,9694,799
Purchase of property, plant and equipment979961
Free cash flow1,9903,838
Cash from investing-657-285
Cash from financing-1,765-2,203
Dividends paid3,5923,572
Filing20-F20-F

USD million. Free cash flow is cash from operations less the purchase of property, plant and equipment, arithmetic on the two filed lines.

Balance sheet

Year toDec 2019Dec 2020
Funded by
Equity attributable to shareholders13,12715,622
Non-controlling interests1,46916.0
Borrowings, as filed17,55219,699
Lease liabilities675681
Other liabilities28,55430,711
Total equity and liabilities61,37766,729
Owned
Property, plant and equipment7,6888,251
Goodwill11,66811,845
Other intangible assets20,83320,947
Cash and cash equivalents5,3697,832
Trade and other receivables5,7617,022
Inventories3,1934,024
Other assets6,8656,808
Total assets61,37766,729
Filing20-F20-F

USD million, at each fiscal year end.

Ratios on the filed lines

Year toDec 2019Dec 2020
Gross margin79.8%80.1%
Operating margin12.0%19.4%
Net margin5.5%12.0%
Free cash flow margin8.2%14.4%
Return on year-end equity10.2%20.5%
Effective tax rate20.7%19.7%
Filing20-F20-F

Arithmetic on the filed lines of the same year.

20-F for the year to 31 December 2020, filed 21 February 2023: the filing. The figures are in US dollars as filed.